304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma

oleh: Kim Margolin, Antoni Ribas, Riyue Bao, Adil Daud, Mohammed Milhem, Elizabeth Buchbinder, Geoffrey Gibney, Jason Luke, Takami Sato, David Mauro, Yousef Zakharia, Theresa Medina, John Kirkwood, Jiaxin Niu, Katie Campbell, George Weiner, Inderjit Mehmi, Heather Kelley, James Wooldridge

Format: Article
Diterbitkan: BMJ Publishing Group 2020-11-01

Deskripsi

No description available for this item.